• Je něco špatně v tomto záznamu ?

Investigation of potential ascorbate peroxidase inhibitors for anti-leishmaniasis therapy

AA. Rabaan, MA. Alshahrani, B. Othman, M. Alfaresi, YA. Almutawif, HMA. Eid, A. Saif, AA. Alshehri

. 2025 ; 70 (2) : 371-390. [pub] 20240817

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25013017

L eishmaniasis is a prevalent disease that impacts 98 countries and territories, mainly in Africa, Asia, and South America. It can cause substantial illness and death, particularly in its visceral manifestation that can be specifically targeted in the development of medications to combat leishmaniasis. This study has found natural compounds with possible inhibitory activity against APX using a reliable and accurate QSAR model. Despite the severe side effects of current treatments and the absence of an effective vaccination, these compounds show promise as a potential treatment for the disease. Nine hit compounds were found, and subsequent molecular docking was performed. Estradiol cypionate showed the lowest binding energy (- 10.5 kcal/mol), thus showing the strongest binding, and also had the strongest binding affinity, with a ΔGTotal of - 26.31 ± 3.01 kcal/mol, second only to the control molecule. Additionally, three hits viz. cloxacillin-sodium (- 16.57 ± 2.89 kcal/mol), cinchonidine (- 16.04 ± 3.27 kcal/mol), and quinine hydrochloride dihydrate (13.38 ± 1.06 kcal/mol) also showed significant binding affinity. Multiple interactions between drugs and active site residues demonstrated a substantial binding affinity with the target protein. The identified compounds exhibited drug-like effects and were orally bioavailable based on their ADME-toxicology features. Overall, estradiol cypionate, cloxacillin sodium, cinchonidine, and quinine hydrochloride dihydrate all exhibited inhibitory effects on the APX enzyme of Leishmania donovani. These results suggest that further investigation is needed to explore the potential of developing novel anti-leishmaniasis drugs using these compounds.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25013017
003      
CZ-PrNML
005      
20250605092910.0
007      
ta
008      
250605s2025 xr f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s12223-024-01190-z $2 doi
035    __
$a (PubMed)39153157
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Rabaan, Ali A $u Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, 31,311, Dhahran, Saudi Arabia. arabaan@gmail.com $u College of Medicine, Alfaisal University, Riyadh, Saudi Arabia, 11,533. arabaan@gmail.com $u Department of Public Health and Nutrition, The University of Haripur, Haripur, Pakistan, 22,610. arabaan@gmail.com $1 https://orcid.org/0000000267749847
245    10
$a Investigation of potential ascorbate peroxidase inhibitors for anti-leishmaniasis therapy / $c AA. Rabaan, MA. Alshahrani, B. Othman, M. Alfaresi, YA. Almutawif, HMA. Eid, A. Saif, AA. Alshehri
520    9_
$a L eishmaniasis is a prevalent disease that impacts 98 countries and territories, mainly in Africa, Asia, and South America. It can cause substantial illness and death, particularly in its visceral manifestation that can be specifically targeted in the development of medications to combat leishmaniasis. This study has found natural compounds with possible inhibitory activity against APX using a reliable and accurate QSAR model. Despite the severe side effects of current treatments and the absence of an effective vaccination, these compounds show promise as a potential treatment for the disease. Nine hit compounds were found, and subsequent molecular docking was performed. Estradiol cypionate showed the lowest binding energy (- 10.5 kcal/mol), thus showing the strongest binding, and also had the strongest binding affinity, with a ΔGTotal of - 26.31 ± 3.01 kcal/mol, second only to the control molecule. Additionally, three hits viz. cloxacillin-sodium (- 16.57 ± 2.89 kcal/mol), cinchonidine (- 16.04 ± 3.27 kcal/mol), and quinine hydrochloride dihydrate (13.38 ± 1.06 kcal/mol) also showed significant binding affinity. Multiple interactions between drugs and active site residues demonstrated a substantial binding affinity with the target protein. The identified compounds exhibited drug-like effects and were orally bioavailable based on their ADME-toxicology features. Overall, estradiol cypionate, cloxacillin sodium, cinchonidine, and quinine hydrochloride dihydrate all exhibited inhibitory effects on the APX enzyme of Leishmania donovani. These results suggest that further investigation is needed to explore the potential of developing novel anti-leishmaniasis drugs using these compounds.
650    _2
$a simulace molekulového dockingu $7 D062105
650    12
$a antiprotozoální látky $x farmakologie $x chemie $7 D000981
650    12
$a inhibitory enzymů $x farmakologie $x chemie $7 D004791
650    _2
$a kvantitativní vztahy mezi strukturou a aktivitou $7 D021281
650    12
$a leishmanióza $x farmakoterapie $7 D007896
650    _2
$a zvířata $7 D000818
650    _2
$a lidé $7 D006801
655    _2
$a časopisecké články $7 D016428
700    1_
$a Alshahrani, Mohammed Abdulrahman $u Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Najran University, Najran, Saudi Arabia, 61,441
700    1_
$a Othman, Basim $u Department of Public Health, Faculty of Applied Medical Sciences,, Albaha University, Albaha, Saudi Arabia, 65,77
700    1_
$a Alfaresi, Mubarak $u Department of Microbiology, National Reference Laboratory, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates, 92,323 $u Department of Pathology, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates, 505,055
700    1_
$a Almutawif, Yahya A $u Department of Medical Laboratories Technology, College of Applied Medical Sciences, Taibah University, Madinah, Saudi Arabia, 41,411
700    1_
$a Eid, Hamza M A $u Department of Medical Laboratories Technology, College of Applied Medical Sciences, Taibah University, Madinah, Saudi Arabia, 41,411
700    1_
$a Saif, Ahmed $u Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia, 62,223
700    1_
$a Alshehri, Ahmad A $u Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Najran University, Najran, Saudi Arabia, 61,441. aaalshehri@nu.edu.sa
773    0_
$w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 70, č. 2 (2025), s. 371-390
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39153157 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250605 $b ABA008
991    __
$a 20250605092904 $b ABA008
999    __
$a ok $b bmc $g 2333594 $s 1250127
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 70 $c 2 $d 371-390 $e 20240817 $i 1874-9356 $m Folia microbiologica $n Folia Microbiol (Praha) $x MED00011005
LZP    __
$a Pubmed-20250605

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...